+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Ophthalmology Therapeutics Market 2023-2027 - Product Thumbnail Image

Ophthalmology Therapeutics Market 2023-2027

  • Report
  • December 2022
  • 170 Pages
  • Global
From
Diagnostic Specialty Antibodies Market Report 2025 - Product Thumbnail Image

Diagnostic Specialty Antibodies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Head and Neck Cancer Diagnostics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Diagnostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-CD20 antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD20 antibody - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Severe Hypertriglyceridemia - Pipeline Insight, 2024 - Product Thumbnail Image

Severe Hypertriglyceridemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 70 Pages
  • Global
From
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
ANGPTL3 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ANGPTL3 protein inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Loading Indicator